INTRODUCTION {#h0.0}
============

Positive-stranded RNA viruses form intracellular membrane-bound organelles after infection, and these organelles are believed to facilitate intracellular RNA replication ([@B1], [@B2]). In the coronaviruses, which cause diseases in humans, including severe acute respiratory syndrome (SARS) and Middle Eastern respiratory syndrome (MERS), these replicative structures take the form of double-membrane vesicles (DMV), which later develop into clusters where the outer DMV membranes are connected by a network of convoluted membrane (CM) tubules ([@B3][@B4][@B5]). DMV clusters are derived from the endoplasmic reticulum (ER) or ER-Golgi intermediate compartment ([@B4], [@B6]) and contain newly synthesized viral RNA and viral replicase proteins ([@B4], [@B7][@B8][@B13]). Previous reports have linked organelle formation to ongoing RNA replication ([@B4], [@B14], [@B15]). This has been interpreted as evidence that DMVs either are required for coronavirus RNA synthesis or are generated as a result of viral RNA synthesis ([@B4], [@B14]).

The SARS coronavirus (SARS-CoV) replicative machinery consists of up to sixteen nonstructural proteins (nsp1 to nsp16), which are processed from large polyproteins (reviewed in reference [@B16]). The conserved gene cluster from the nsp3 gene to the nsp6 gene contains all the factors necessary for DMV formation: nsp3, nsp4, and nsp6 are needed to form DMV clusters ([@B17]) after essential processing by proteinases located in nsp3 ([@B18]) and nsp5 ([@B19]). Electron microscopy suggests that nsp3 induces membrane proliferation ([@B17]). nsp3 and nsp4 localize predominantly to the CM in DMV clusters ([@B4], [@B9], [@B20]) and are sufficient to induce structures resembling CMs in the absence of other viral proteins ([@B17]). Mutations in nsp4 have been linked to formation of aberrant DMVs with apparent defects in membrane pairing ([@B21]). nsp6 from several coronaviruses causes single-membrane LC3-containing vesicles ([@B22]) to accumulate around microtubule organization centers ([@B17]), although it is not clear how this is connected to the formation of DMV clusters.

Some replicase subunits work together in units known as cistrons. Five cistrons (0, I, II, IV, and VI) have been defined, with gaps left in the naming scheme in case new cistrons are discovered that map to nsp13 and nsp15, respectively ([@B14], [@B23]). Complementation studies using temperature-sensitive (*ts*) mutants of mouse hepatitis virus (MHV) have showed that mutations in nsp3, nsp12, nsp14, and nsp16 protein define distinct cistrons (cistrons 0, II, IV, and VI, respectively), while mutations in nsp5 and nsp10 proteins define a single cistron (cistron I) ([@B14], [@B23][@B24][@B25]). Temperature-sensitive mutations in coronavirus nsp3, nsp5, nsp10, nsp12, nsp14, and nsp16 have been reported, all of which permit RNA synthesis at 33°C but cause RNA synthesis defects at 40°C ([@B14], [@B24][@B25][@B28]).

In this study, we examined the intracellular organelle phenotype of MHV strains with temperature-sensitive (*ts*) mutations in each of the known cistrons. Both mutant and control viruses were grown at 33°C, a temperature selected to allow full growth of mutant viruses. We chose to work with *ts* viruses as a pool of ready-made replicase point mutants that have been preselected for both robust growth at 33°C and functional importance, since each of the *ts* mutations is lethal at 40°C. We carried out these tests in order both to better understand the connection between organelles and viral RNA synthesis and to examine whether mutation of critical residues produces a detectable effect on the replicative organelle. To do this, we quantified virus release, DMV formation, RNA synthesis, and competitive fitness in a variety of cell types.

RESULTS {#h1}
=======

Genetics and growth of mutant viruses. {#h1.1}
--------------------------------------

Wild-type MHV-inf-1 and five mutant MHV strains selected on the basis of defective RNA synthesis at 40°C were used in this study ([Fig. 1](#fig1){ref-type="fig"}). Br*ts*31 contains a mutation in a region that likely forms an interdomain flexible linker in nsp3 ([@B29], [@B30]), which paradoxically interferes with the function of the nsp5 main proteinase (M^pro^) at 40°C ([@B14]). Alb*ts*16 has a mutation in a loop within the carboxyl-terminal domain of M^pro^ ([@B23], [@B31]). Alb*ts*22 has a mutation in the predicted thumb domain of the polymerase fold near the carboxyl terminus of nsp12 ([@B23], [@B32]). Wü*ts*18 has a mutation on the surface of the viral 2′-*O*-methyltransferase ([@B23], [@B33]). The last mutant chosen was the previously undescribed Br*ts*105, which contains a single proline to serine substitution (CCA to UCA) at position 19320 in sequence AY700211 ([Fig. 1](#fig1){ref-type="fig"}). The Br*ts*105 mutation falls in the viral N7-methyltransferase domain of nsp14 ([@B34]), between the previously characterized Wü*ts*38 and Alb*ts*17 mutations, both of which map to cistron IV ([@B23]).

![Genetic characteristics of MHV mutants. The schematic shows amino acid changes responsible for temperature-sensitive phenotypes of viruses used in this study. Amino acid positions are numbered from the start of each nonstructural protein. Functions of potentially affected domains that are marked include papain-like proteinases (PL1^pro^ and PL2^pro^), ADP-ribose 1ʺ phosphatase (ADRP), main proteinase (M^pro^), RNA-dependent RNA polymerase (RdRp), and methyltransferases (N7-MT and 2O-MT).](mbo0021417790001){#fig1}

Br*ts*105 was subjected to several tests to characterize its growth at 33°C and 40°C. The replication of Br*ts*105 was compared to that of both the wild type and the better-characterized Br*ts*31 mutant in primary mouse embryo fibroblast cells ([Fig. 2A](#fig2){ref-type="fig"}). Br*ts*105 growth was slightly delayed compared to that of the wild type and Br*ts*31 but reached a similar peak titer. Neither Br*ts*105 nor Br*ts*31 virus grew at 40°C ([Fig. 2B](#fig2){ref-type="fig"}), and Br*ts*105 did not produce RNA at 40°C ([Fig. 2C](#fig2){ref-type="fig"}), demonstrating that growth of both viruses was temperature sensitive.

![Characterization of Br*ts*105 growth. Viruses were inoculated at a multiplicity of 10 PFU/cell on primary MEFs (mouse embryo fibroblasts) at 33°C for 1 h and then incubated at either 33°C (A) or 40°C (B) for the duration of the experiment. Viral growth was measured by plaque assay at 33°C. The average of three replicates is shown. Dotted lines indicate the lower limit of detection for the plaque assay. (C) Northern blots show the effect of temperature on viral RNA production by the wild type and Br*ts*105. Bands corresponding to viral subgenomic RNAs 4 to 7 are indicated. (D to F) The relative severity of *ts* phenotypes was characterized by a growth stop/resume assay. Growth was stopped 4.5 h after inoculation by incubating *ts* virus at 40°C or by treating wild-type virus with 10 µg/ml cycloheximide (CHX). After 3 h of arrested growth, the inhibition was either maintained to the end of the experiment (Stopped) or released (Resumed). Virus growth was measured by plaque assay, and the results for Br*ts*105 are shown in panel E. The averages for 6 replicates are shown. The titer ratio (resumed to stopped) from panel E is shown in comparison to other mutants and CHX treatment in panel F. Statistically significant increases in titer after resumption are indicated (\*, *P* ≤ 0.05; ns, not significant).](mbo0021417790002){#fig2}

Functional characterization of *ts* viruses. {#h1.2}
--------------------------------------------

To better understand the functional consequences of activating the *ts* phenotype of Br*ts*105, we performed a stop/resume assay, which was designed as a simple tool to compare the severity of *ts* phenotypes. The assay takes advantage of the eclipse phase, during which RNA replication takes place but no new virus emerges, which lasts for 6 h after inoculation ([@B5]). The stop/resume assay works by stopping RNA synthesis 4.5 h after inoculation, during the eclipse phase. After 3 h under stopped conditions, RNA synthesis was then either resumed for 4 h, in order to allow the release of new virus with the participation of previously synthesized components, or kept under stopped conditions ([Fig. 2D](#fig2){ref-type="fig"}). If the resumed titer was significantly higher than the stopped titer (typically about a 10-fold increase), then the *ts* phenotype was classified as mild, meaning that some residual function or functional components were available after the stoppage period, but if the titer did not increase significantly after resumption, then the *ts* phenotype was classified as severe.

The results of a stop/resume assay for Br*ts*105 are shown in [Fig. 2E](#fig2){ref-type="fig"} and were typical of the mild phenotype. Stop/resume assays were performed at least twice, with three replicates per time point. Results for other viruses are summarized in [Fig. 2F](#fig2){ref-type="fig"}. Br*ts*105, Br*ts*31, and Alb*ts*16 displayed mild *ts* phenotypes. This was consistent with the previously described mild *ts* phenotype of Alb*ts*16 ([@B23]). The *ts* phenotype of Alb*ts*22 was found to be severe, as previously reported ([@B23]), and was equivalent in severity to treatment with cycloheximide, which blocks translation and has been shown to result in inactivation of replicase components in about 1 h ([@B23], [@B35], [@B36]).

We next compared the growth of the panel of viruses at 33°C on continuous 17Clone-1 fibroblasts (17Cl-1), primary mouse embryo fibroblasts (MEFs), adipose-derived mesenchymal stem cells (ADMSC), and bone marrow-derived stem cells (BMSC) ([Table 1](#tab1){ref-type="table"}). All of the mutants except Alb*ts*22 grew to approximately wild-type levels at 33°C in every cell type tested. Alb*ts*16 grew slightly slower than the wild type in 17Cl-1 cells but grew to wild-type levels in MEFs. Alb*ts*22 consistently produced about one-tenth as many infectious progeny as wild-type virus. These results showed that, except for Alb*ts*22, the panel of mutants displayed growth characteristics similar to those of wild-type virus at 33°C. These results were consistent with previous results, which showed that Wü*ts*18 ([@B37]) and Br*ts*31 ([@B14]) grow to wild-type levels at 33°C, while growth of Alb*ts*22 is attenuated even at 30°C ([@B23]).

###### 

Comparative growth characteristics of MHV mutants^[*a*](#ngtab1.1)^

  ------------------------------------------------------------------------------------------------------------------------------------------------------------
  Cell line   Conditions   Titer (log) of\               Titer difference relative to wild type (log)                                                  
                           wild type^[*b*](#ngtab1.2)^                                                                                                 
  ----------- ------------ ----------------------------- ---------------------------------------------- ------- ---------------------- ------- ------- -------
  17Cl-1      14           33                            6.9 ± 0.3                                      0       −0.6                   −0.2    0.4     −0.8

  MEF         24           33                            5.3 ± 0.4                                      0.1     −0.4                   −0.3    0.1     −1

  MEF         48           33                            7.1 ± 0.2                                      −0.2    ND^[*c*](#ngtab1.3)^   0       ND      ND

  MEF         72           33                            4.6 ± 0.4                                      ND      0                      ND      ND      ND

  ADMSC       48           33                            6.2 ± 0.1                                      0.1     ND                     ND      ND      ND

  BMSC        18           33                            3.8 ± 0.2                                      0       ND                     ND      ND      ND

  17Cl-1      14           40                            5.1 ± 0.2                                      ≤−3.8   −3.4                   ≤−3.8   −2.7    ≤−3.8

  MEF         24           40                            5.6 ± 0.2                                      ≤−4.3   ≤−4.3                  ≤−4.3   ≤−4.3   −3.5
  ------------------------------------------------------------------------------------------------------------------------------------------------------------

Effects of mutations on viral growth were assessed at permissive (33°C) and nonpermissive (40°C) temperatures in continuous (17Cl-1) and primary (MEF, ADMSC, and BMSC) cell cultures. Titer differences were calculated from a minimum of three replicates.

The wild-type titer is shown as the mean ± standard deviation.

ND, not determined.

Aberrant DMV formation at 33°C. {#h1.3}
-------------------------------

Cells were infected at high multiplicity with wild-type or mutant viruses and then examined by electron microscopy to investigate the effects of mutations on replicative organelle formation at 33°C. One randomly oriented ultrathin section per cell was examined in order to compare the sizes and numbers of intracellular organelles virions, as described previously ([@B17]).

Clusters of DMVs were observed next to regions of CM in 17Cl-1 cells infected with wild-type and mutant viruses ([Fig. 3A](#fig3){ref-type="fig"}). However, all of the mutants produced smaller DMVs than wild-type virus, varying from nearly wild-type size (Br*ts*105) to approximately 10% smaller (Br*ts*31, Wü*ts*18, and Alb*ts*22) to 17% smaller (Alb*ts*16). Many DMV-containing cells also contained intracellular virus particles ([Fig. 3B](#fig3){ref-type="fig"}), which did not differ significantly in size from wild-type controls.

![Replicative organelles formed at 33°C by MHV mutants in 17Cl-1 cells. (A) Positions of double-membrane vesicles (stars), intracellular virus (arrowhead), and convoluted membrane (c) in infected cells are marked. (B) Magnified images of intracellular virus particles from each virus.](mbo0021417790003){#fig3}

DMV size was measured in order to better understand the effects of the mutations on DMV synthesis. Altogether, 4,646 DMVs were measured at various times after infection in three continuous cell lines. Under every condition that was tested, mutant viruses formed significantly smaller DMVs than wild-type viruses ([Table 2](#tab2){ref-type="table"}). The only revertant virus tested produced DMVs of wild-type size (Wü*ts*18 revertant in L929 cells in [Table 2](#tab2){ref-type="table"}). To control for the possibility that DMV size differences were due to variation in preparation for electron microscopy, 1,352 intracellular virions were measured from the same micrographs. No significant differences in intracellular virion size were observed ([Table 2](#tab2){ref-type="table"}). Together, this demonstrated that Br*ts*31, Alb*ts*16, Alb*ts*22, Br*ts*105, and Wü*ts*18 have small DMV phenotypes at 33°C.

###### 

DMV and virion size in infected cells

  Conditions                             Virus                         *ts*                      Double-membrane vesicles   Intracellular virions                                 
  -------------------------------------- ----------------------------- ------------------------- -------------------------- ----------------------- ------------- ----- --------- ----------------------
  L929, 37°C, 5 hpi^[*c*](#ngtab2.3)^    Wild-type                                               302                        179 ± 36                              63    75 ± 9    
                                         Wü*ts*18                      nsp16                     196                        157 ± 61                2 × 10^−6^    77    75 ± 8    NS^[*d*](#ngtab2.4)^
                                         Revertant                     nsp16^[*e*](#ngtab2.5)^   165                        178 ± 31                NS            42    77 ± 13   NS
  DBT, 33°C, 5.5 hpi                     Wild type                                               468                        228 ± 45                              74    69 ± 8    
                                         Br*ts*31                      nsp3                      58                         195 ± 38                2 × 10^−6^    70    69 ± 9    NS
  DBT, 40°C, 5.5 hpi^[*f*](#ngtab2.6)^   Wild type                                               841                        218 ± 50                9 × 10^−5^    141   71 ± 10   NS
  17cl1, 33°C,10 hpi                     Wild type                                               604                        228 ± 36                              169   68 ± 10   
                                         Br*ts*31                      nsp3                      403                        208 ± 34                5 × 10^−19^   263   68 ± 10   NS
                                         Alb*ts*16                     nsp5                      459                        189 ± 33                8 × 10^−66^   102   70 ± 8    NS
                                         Br*ts*105                     nsp14                     463                        220 ± 36                2 × 10^−4^    278   69 ± 10   NS
                                         Wü*ts*18                      nsp16                     456                        211 ± 35                2 × 10^−15^   39    67 ± 12   NS
                                         Alb*ts*22^[*g*](#ngtab2.7)^   nsp12                     231                        204 ± 43                2 × 10^−13^   34    68 ± 11   NS

Size was calculated as perimeter length divided by π; data are means ± standard deviations.

Compared to the wild-type (Wü*ts*18) or revertant (Br*ts*31) control by Mann-Whitney test.

Wü*ts*18 and the revertant grow to wild-type levels at 37°C (41).

NS, not significantly different from the corresponding wild-type control.

Containing the original *ts* mutation in nsp16 plus a compensating mutation in nsp16 N43S.

Incubated at 33°C for 3.5 h and then shifted to 40°C.

Attenuated growth at 33°C compared to the wild type*.*

Fewer DMVs formed at 33°C. {#h1.4}
--------------------------

Ultrathin sections of infected 17Cl-1 and DBT cells were next examined for the prevalence of visible signs of infection in order to determine whether any of the mutations affected the number of DMV clusters present. For the combined viruses, 2,285 ultrathin cell sections were examined for the presence of intracellular signs of infection. Sections containing intracellular virions or DMV clusters were counted and photographed, and the number of each was recorded. Cells inoculated with Br*ts*31 and Br*ts*105 each contained about half the expected number of DMV-positive cells at 33°C compared to the wild type, despite a similar prevalence of cells with intracellular virions visible ([Table 3](#tab3){ref-type="table"}). The prevalence of DMV and virion-containing cells did not differ from that in the wild-type controls for Alb*ts*16 and Wü*ts*18, but Alb*ts*22 produced significantly fewer signs of infection ([Table 3](#tab3){ref-type="table"}). These results demonstrated that Alb*ts*22, Br*ts*31, and Br*ts*105 produced fewer DMV clusters than wild-type virus.

###### 

DMV and intracellular virion (IV) prevalence in infected cells

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Conditions             Virus                         *ts*    No. of\   Prevalence of intracellular signs\   No. per cell section when present   Rel. DMV\                                                                                            
                                                               cells     of infection                                                             capacity (%)^[*b*](#ngtab3.1)^                                                                       
  ---------------------- ----------------------------- ------- --------- ------------------------------------ ----------------------------------- -------------------------------- --------------------- --------- ------------ --------- ------------ ----------
  DBT, 33°C, 5.5 hpi     Wild type                             323       6                                                                        7                                −                     18 ± 20                3 ± 4     −            100 ± 60

                         Br*ts*31                      nsp3    753       2                                    8 × 10^−4^                          7                                NS^[*c*](#nstab3.)^   6 ± 6     1 × 10^−2^   3 ± 4     NS           20 ± 12

  17Cl-1, 33°C, 10 hpi   Wild type                             161       40                                                                       29                                                     9 ± 9                  4 ± 3                  100 ± 48

                         Br*ts*31                      nsp3    238       24                                   4 × 10^−4^                          25                               NS                    7 ± 8     4 × 10^−4^   4 ± 6     NS           35 ± 18

                         Alb*ts*16                     nsp5    120       37                                   NS                                  19                               NS                    9 ± 8     NS           4 ± 4     NS           53 ± 28

                         Br*ts*105                     nsp14   230       22                                   1 × 10^−4^                          32                               NS                    9 ± 13    NS           4 ± 4     NS           49 ± 25

                         Wü*ts*18                      nsp16   140       36                                   NS                                  20                               NS                    9 ± 10    NS           2 ± 1     7 × 10^−3^   71 ± 36

                         Alb*ts*22^[*d*](#ngtab3.3)^   nsp12   *320*     13                                   1 × 10^−5^                          9                                1 × 10^−5^            6 ± 5     NS           1 ± 0.4   1 × 10^−5^   16 ± 10
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Calculated by Fisher's exact test.

Relative DMV capacity was calculated as follows: average DMV size (± standard deviation) × percentage of cell sections with DMVs × DMVs per section, relative to wild-type*.*

Not significantly different from the corresponding wild-type control.

Attenuated growth at 33°C compared to the wild type.

The number of DMVs per cell was measured in order to better quantify differences in organelle prevalence. Br*ts*31 DMV clusters contained about a three-quarters as many DMVs as wild-type clusters both early and late in infection ([Table 3](#tab3){ref-type="table"}). Alb*ts*22 clusters contained about two-thirds as many DMVs as wild-type clusters, consistent with the severely attenuated growth. For all viruses examined, there was one CM present per approximately 7 DMVs and 1 to 5 DMV clusters per cell section, when present (data not shown). Collectively these data distinguish two low-DMV phenotypes that occurred without attenuation of the virus: Br*ts*105 formed fewer DMVs of near-normal size, while Br*ts*31 formed fewer DMVs of smaller-than-normal size.

DMV capacity and RNA synthesis. {#h1.5}
-------------------------------

Viral RNA accumulates in DMVs, leading to the interpretation that DMV clusters are the primary site of RNA replication ([@B4]), although a recent study has called into question whether all DMVs are active in RNA synthesis ([@B38]). In this case, the total DMV capacity in an infected cell may limit the amount of viral RNA synthesis that can take place inside a cell. To estimate total DMV capacity, DMV size ([Table 2](#tab2){ref-type="table"}) was multiplied by the relative percentage of DMV-containing cells ([Table 3](#tab3){ref-type="table"}) and multiplied by the number of DMVs per cluster ([Table 3](#tab3){ref-type="table"}) to estimate the relative DMV capacity of cells infected with wild-type and mutant viruses. Results were normalized to those for wild-type controls grown at 33°C and are shown in [Table 3](#tab3){ref-type="table"}.

It has been previously shown that wild-type MHV produces about twice as much viral RNA at 40°C as at 33°C ([@B23]) ([Fig. 2C](#fig2){ref-type="fig"}). To test whether this increased RNA synthesis was reflected in the number or size of replicative organelles, cells infected with wild-type virus and incubated at 40°C and 33°C were examined. Organelles formed at 40°C were smaller ([Table 2](#tab2){ref-type="table"}) but more numerous (31 per cell compared to 18 per cell at 33°C), effectively doubling DMV capacity ([Fig. 4A](#fig4){ref-type="fig"}). These results demonstrated that conditions reported to increase RNA yield correlated with increased DMV capacity for wild-type MHV.

![RNA synthesis and relative DMV capacity. (A) Relative DMV capacity was estimated as DMV size (± standard deviation) × percentage of cell sections with visible DMVs × average number of DMVs per cell and expressed as a percentage of wild-type DMV capacity (indicated by the dotted line). (B) Viral genomic and subgenomic RNA synthesis at 10 h postinoculation in 17Cl-1 cells was measured by quantitative RT-PCR and is expressed as an amount relative to wild-type RNA synthesis. Statistically significant differences in RNA load are indicated (\*\*\*, *P* ≤ 0.001; ns, not significant).](mbo0021417790004){#fig4}

Alb*ts*22 displayed the lowest relative DMV capacity among the viruses we examined ([Fig. 4A](#fig4){ref-type="fig"}). The nearly tenfold reduction in Alb*ts*22 DMV capacity compared to wild-type corresponded well with nearly tenfold-lower production of infectious progeny ([Table 1](#tab1){ref-type="table"}). However, DMV capacity correlated poorly with yield for Br*ts*31, which produced infectious progeny at wild-type levels despite having only 35% of the DMV capacity of wild-type virus ([Table 3](#tab3){ref-type="table"}). This suggested two possibilities: that Br*ts*31 packages a reduced amount of RNA more efficiently than wild-type virus, or that Br*ts*31 synthesizes normal amounts of RNA from a smaller-than-normal number of organelles.

To discriminate between these possibilities, wild-type and Br*ts*31 RNA synthesis was compared by quantitative RT-PCR. Genomic and subgenomic RNA 7 synthesis was quantified using primers specific to the nsp3-encoding region and across the leader-body junction of subgenomic RNA 7, respectively. Br*ts*31 synthesized somewhat larger amounts of genomic and subgenomic RNA than the wild type at 33°C, as shown in [Fig. 4B](#fig4){ref-type="fig"}. Together, these data demonstrate that efficient RNA production is not necessarily correlated with large or numerous DMVs.

DMVs and fitness. {#h1.6}
-----------------

To better understand the role of DMV formation in the virus replication cycle, we carried out competitive fitness assays on all the viruses that grew to approximately wild-type titers. In these assays, an equal number of plaque-forming units of wild-type virus and one ts virus were added at low multiplicity to either continuous or primary cells, which were then incubated at 33°C. Fitness was calculated as the ratio of mutant virus to wild-type virus present in the supernatant at the end of the competition. In this assay, a ratio of 1 would indicate that the viruses were equally fit, higher ratios indicate that the mutant virus is fitter than the wild type, and lower ratios indicate that the mutant virus is less fit than the wild type. Viruses were differentiated by means of plaque assays initiated at 33°C for 1 h and then continued by incubation at either 40°C (where only the wild type forms plaques) or 33°C (where both viruses form plaques). The assay was validated by performing differential plaque assays on pure samples of the wild type and Br*ts*105 ([Fig. 5A](#fig5){ref-type="fig"}). The number of plaques formed by the wild type did not differ significantly at the two temperatures. Br*ts*105 formed plaques in 33°C plaque assays but not in plaque assays initiated at 33°C and then continued by incubation at 40°C ([Fig. 5A](#fig5){ref-type="fig"}). This demonstrated that titers of wild-type and *ts* viruses can be distinguished by differential plaque assays and that the reversion rate of Br*ts*105 was less than 10^−5^ and therefore would not detectably complicate the interpretation of competition experiments, which typically produced more than 10^6^ PFU/ml.

![Viral fitness assay validation and results. (A) Numbers of plaques generated by samples of the wild type and Br*ts*105. Plaque assays were inoculated at 33°C for 1 h and then incubated at 33°C and 40°C. Results were normalized to the average titer obtained from the 33°C plaque assays and are averages for 14 replicates for the wild type or 8 replicates for Br*ts*105. A titer below the 25-PFU/ml lower limit of detection is indicated (\<). (B) Relative fitness of MHV mutants in continuous 17Cl-1 and primary MEFs, as determined by plaque assays at both 33°C and 40°C for each sample. Fitness is expressed as (33°C titer − 40°C titer)/40°C titer. Error bars show standard deviation. Statistically significant differences between the titer of *ts* virus (33°C titer − 40°C titer) and wild-type virus (40°C titer) are indicated (\*, *P* ≤ 0.05; ns, not significant; nt, conditions not tested). (C) DNA sequencing results for the wild type, Br*ts*105, and a 1:1 mixture of wild-type and Br*ts*105 viruses. (D) Results of competitive fitness assays performed in triplicate with 1:1, 3:1, and 5:1 ratios of Br*ts*105 to wild-type virus as determined by RT-PCR and DNA sequencing. Results are ratios of the two viruses based on peak height from direct cDNA sequencing and are from three replicate sequences.](mbo0021417790005){#fig5}

Br*ts*105 and Wü*ts*18 showed a small but statistically significant increase in fitness compared to the wild type, Br*ts*31 and Alb*ts*16 did not differ significantly in fitness from the wild type, and Alb*ts*22 appeared somewhat but not significantly less fit than the wild type in continuous cells ([Fig. 5B](#fig5){ref-type="fig"}). Results from primary MEFs agreed with continuous-cell results. This also showed that Br*ts*105 and Wü*ts*18 are cold adapted compared to wild-type virus, in addition to being *ts*. This demonstrated that viruses that produce larger replicative organelles ([Fig. 5](#fig5){ref-type="fig"}) (Alb*ts*16, Wü*ts*18, and Br*ts*31 versus the wild type) or more numerous replicative organelles ([Fig. 5](#fig5){ref-type="fig"}) (Br*ts*31 and Br*ts*105 versus the wild type) do not have a competitive disadvantage *per se* under these assay conditions.

In order to further test whether the differential plaque assay results reflected the proportion of wild-type and *ts* RNA released into the supernatant at the end of a competition assay in 17Cl-1 cells, RT-PCR and DNA sequencing ([@B39]) were performed for competition assays containing Br*ts*105 and wild-type virus ([Fig. 5C and D](#fig5){ref-type="fig"}). In this assay, three replicates gave a fitness of 0.8 ± 0.1 for Br*ts*105, which fell within the range of results recorded by plaque assay (0.4 to 6.4). The parity between Br*ts*105 and the wild type was maintained even when the relative abundance of each virus at the beginning of the competition was altered ([Fig. 5D](#fig5){ref-type="fig"}). This confirmed that Br*ts*105 was not significantly less fit than wild-type virus under these test conditions.

DISCUSSION {#h2}
==========

The formation of replicative organelles is a conserved strategy among positive-stranded viruses and has led to the assumption that viral organelles play an important and highly conserved role in intracellular RNA replication ([@B1], [@B2]). Previous studies had shown that newly synthesized viral RNA can be detected as early as 1 h after inoculation ([@B40]), but the earliest time at which DMVs have been detected is 2 h after inoculation ([@B4], [@B5]), and complete organelles with CM and DMVs were first reported 3 h after inoculation with MHV ([@B5]) or 4 h after inoculation with SARS-CoV ([@B4]), suggesting that the replicative organelle may be a lagging indicator of viral RNA synthesis. However, other studies have shown that replicative organelles disappear within about 2 h of treatments that strongly inhibit viral RNA synthesis ([@B14], [@B15]). In this study, we documented viruses with a range of organelle sizes and prevalence that were sufficient to support wild-type levels of viral growth. This included two viruses of the six tested (Br*ts*31 and Br*ts*105) that replicated normally with half the normal complement of organelles or less. These results extend findings that attenuated nsp4 mutant viruses produce fewer organelles than normal ([@B21]). Together, these results suggest that there is a considerable plasticity in the replication complex, since a variety of sizes and numbers of DMVs can support RNA synthesis.

The data presented here do not necessarily disprove that DMV clusters are needed for intracellular coronavirus RNA synthesis but demonstrate that the link may be looser than anticipated. This finding was anticipated by a recent study that demonstrated that subcellular compartments that contain double-stranded RNA (dsRNA) (i.e., probable DMVs) were not necessarily sites of active RNA replication ([@B38]). We unexpectedly found that viruses that produced larger and more numerous DMVs did not have a consistent fitness advantage in primary or continuous cells under test conditions. However, it is quite possible that further testing in primary macrophages or live animals would reveal a competitive advantage for increased organelle numbers or increased DMV capacity. A previous analysis of coronavirus RNA replication had shown that viral dsRNA colocalizes well with nonstructural proteins early in infection but that the correlation becomes less clear over time ([@B38]). Nevertheless, these results are the first direct evidence to our knowledge that intracellular RNA synthesis can be at least partially decoupled from formation of replicative organelles. We also report here for the first time that viruses with mutations in all 5 known cistrons of the MHV replicase form either slightly or substantially smaller DMVs, suggesting that while DMVs are formed primarily by nsp3, nsp4, and nsp6 mutants ([@B17]), mutations in any part of the replicase locus can potentially restrict DMV formation. This suggests that the size and potentially the form of the replicative organelle may be dependent on factors other than the amount of RNA synthesis, such as the efficiency of polyprotein processing.

DMVs are complex, containing viral replicase subunits, RNA, host membranes, and host proteins ([@B4], [@B5], [@B7][@B8][@B13], [@B41], [@B42]), so some changes in DMV size and number may be related to the efficiency of the many poorly understood processes that contribute to DMV formation. The results presented here should be taken with two caveats: that the effects of the mutations may be indirect, and that comparisons of growth and competition could be performed only at reduced temperature. Although all *ts* viruses except for Alb*ts*22 matched the output of the wild type at reduced temperature, reduced temperature may affect replication and the processes that lead to DMV formation differently.

The effect of the Br*ts*31 mutation in reducing DMV formation may be explained by the essential role of nsp3 in organelle formation ([@B17]). However, we could not find a simple explanation for finding that the Br*ts*105 mutation in nsp14, located over 15,000 nucleotides (nt) downstream of the Br*ts*31 mutation, in a domain which had not previously been shown to be essential for DMV synthesis, also reduced organelle formation. While it is possible that the N7 methyltransferase activity of nsp14 is involved in an early step of DMV formation, a more likely explanation is that the mutation alters long-range protein folding or protein processing that occurs upstream of DMV formation, as observed previously for mutations in nsp10 and nsp3 ([@B14], [@B27]). However, further work will be needed to study the effects of the Br*ts*105 mutation on the function of other essential replicase proteins such as nsp5 ([@B14], [@B27]) or protein complexes such as the nsp10-nsp14-nsp16 RNA cap methylation complex ([@B43]). Notwithstanding, the results presented here constitute the first demonstration of a functional linkage between nsp14 and the DMV scaffold proteins.

MATERIALS AND METHODS {#h3}
=====================

Viruses and cells. {#h3.1}
------------------

Wild-type control virus MHV-A59 and Br*ts*31 were propagated from recombinant vaccinia virus-based infectious clones as described previously ([@B14]). MHV-Br*ts*105 was isolated following selection with 150 µg/ml of 5-fluorouracil at 33°C for 16 h using the procedure described for Br*ts*31 ([@B14]). MHV-Br*ts*105, Alb*ts*16, Wü*ts*18, and Alb*ts*22 mutants were plaque purified twice on 17Cl-1 cells and completely sequenced to confirm the presence of the appropriate *ts* mutation and the absence of other changes. 17Cl-1, DBT, and L929 cells were grown in Dulbecco's modified Eagle medium (DMEM; Invitrogen) supplemented with 5% tryptose phosphate broth (TPB; Sigma), 10% heat-inactivated fetal bovine serum (FBS; Biosera), antibiotics, and nonessential amino acids (NEAA; Invitrogen). Primary mouse embryo fibroblasts (Lonza), adipose-derived mesenchymal stem cells (Cyagen), and bone marrow-derived mesenchymal stem cells (obtained from Darwin Prockop at the Health Science Center of Texas A&M University, Bryan, TX) were cultured in DMEM supplemented with 10% FBS, NEAA, and antibiotics. Virus titers were determined by plaque assay on 17Cl-1 cells.

Northern blotting. {#h3.2}
------------------

RNA for Northern blotting was obtained by infecting \~10^7^ 17Cl-1 cells with virus at a multiplicity of 10 PFU per cell for 8 h at 33°C or 6 h at 39.5°C and isolating total RNA using the Trizol reagent (Invitrogen, Paisley, United Kingdom) as described by the manufacturer. The poly(A)-containing RNA was isolated using oligo(dT)~25~ Dynabeads (Dynal, Oslo, Norway) as previously described ([@B44]). The RNA was then incubated with formamide (50%) and formaldehyde (2.2 M) at 70°C for 10 min and electrophoresed in a 1% agarose gel containing 20 mM MOPS (3-*N*-morpholinopropanesulfonic acid) and 600 mM formaldehyde. After electrophoresis, the gel was soaked in 0.05 N NaOH, neutralized, and equilibrated with 20× SSC (3 M NaCl, 0.3 M sodium citrate, 1 mM EDTA) before being vacuum blotted onto a nylon membrane (Optitran BA-S 83; Schleicher and Schuell, Sigma-Aldrich, Poole, United Kingdom). The RNA was cross-linked to the membrane using UV light, and MHV RNAs were detected by hybridization with a 466-bp, α-^32^P-, random-prime-labeled PCR product corresponding to sequences in the nucleocapsid protein open reading frame of the MHV-A59 genome ([@B45]).

Quantitative reverse transcriptase PCR (qRT-PCR). {#h3.3}
-------------------------------------------------

Duplicate flasks were prepared so that RNA extraction and DMV analysis could be performed on samples from the same experiment. Total cellular RNA was extracted from infected cells 10 h after inoculation using an RNeasy minikit (Qiagen). The RNA integrity was analyzed with the 2100 Bioanalyzer using the RNA 6000 Nano kit (Agilent). Both cDNA synthesis and PCR were performed in a single tube from total RNA using the SensiMix SYBR one-step kit (Bioline). Genomic RNA was quantified by amplifying a 124-bp region from the nsp3 gene with the forward primer 5′ AATAAGCAGGAGGCAAATGTTC 3′ and the reverse primer 5′ CCCACAACACAATGAAACAAATC 3′. A 110-nt amplicon spanning the leader-body junction of sgRNA7 was amplified using forward primer 5′ GTACCCTCTCAACTCTAAAAC 3′ and reverse primer 5′ GCGGTTTACAGAGGAGCTT 3′. Amplifications were carried out in triplicate, with a 250 nM primer concentration in 25-µl reaction volumes. Melt curve analysis was performed to confirm PCR product specificity. Absolute quantitation was performed by comparison to a standard curve of cloned amplicons.

Electron microscopy. {#h3.4}
--------------------

Cells were inoculated with at least 20 PFU of virus per cell and maintained at 33°C. Infected cells were fixed in electron microscopy-grade 4% glutaraldehyde (Sigma) in 0.1 M cacodylate buffer, scraped from the plate, and then postfixed in 0.1 M cacodylate-buffered 1% osmium tetroxide for 1 h. The cells were dehydrated in increasing concentrations of acetone and then embedded in Agar 100 resin (Agar Scientific). Ultrathin sections that produced a silver interference pattern (50 to 60 nm in thickness) were taken from embedded samples and poststained with 0.5% uranyl acetate. Electron microscopy was performed at 80 kV on a Philips CM20 equipped with a 2K charge-coupled devide (CCD) camera or a Hitachi H600 equipped with film. Film negatives were scanned into digital files using a Microtek i800 scanner. Cell sections used here each contained a single visible nucleus, with intact nuclear and plasma membranes. Images of DMV- and virion-containing cells meeting these criteria were captured for later analysis.

Measurement of intracellular features was done using the boxer module of EMAN ([@B46]). The longest and shortest diameters of each DMV and intracellular virus particle were measured twice each by two observers. The standard deviation between repeated measurements was about 2 pixels on average, which equated to approximately 7 nm at the level of the specimen. Since most of the DMVs and virions had an elliptical profile, size was estimated by Ramanujan's first approximation for the perimeter of ellipse, and the result was divided by π to approximate diameter.

Competitive fitness assays. {#h3.5}
---------------------------

Continuous 17Cl-1 cells or primary MEFs (mouse embryo fibroblasts) were inoculated with a mixed virus pool containing 0.005 PFU per cell each of wild-type virus and one *ts* mutant. Cells were incubated at 33°C for 24 h on 17Cl-1 or 48 h on MEFs to allow the viruses to complete several rounds of replication. Relative amounts of wild-type and mutant virus were quantified either by RT-PCR following the method of Hall and Little ([@B39]) or by two replicate plaque assays, of which both were inoculated at 33°C for 1 h and then one was incubated at 33°C and the other at 40°C for 3 days. For RT-PCR quantification, released virus was concentrated by precipitation with 10% polyethylene glycol 8000 and purified by pelleting through a sucrose-TNE (10 mM Tris, 100 mM NaCl, 1 mM EDTA) cushion (25% \[wt/vol\] sucrose in 50 mM Tris-HCl \[pH 7.4\], 100 mM NaCl, and 0.1 mM EDTA). RNA was extracted from purified virus using an RNeasy minikit (Qiagen). Purified wild-type and Br*ts*105 RNAs were mixed in molar ratios from 1:5 to 5:1 for use as standards at this stage. Virion RNA and standards were converted to cDNA by reverse transcription with random hexamer primers and amplified with primers bracketing the mutation in Br*ts*105, forward primer 5′ GCAATAGGTATGATGTGTG 3′ and reverse primer 5′ GCTGTGGTTGCCGTATTGTAAG 3′. Amplicons were then sequenced commercially (Source Bioscience) using the same MHV-specific primers. Results were regressed to the proportion of sequencing peak height, normalized to standards.
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